Aging Gracefully: Does Elexacaftor/Tezacaftor/Ivacaftor Safety and Efficacy Stand the Test of Time? [PDF]
Wilson G, Hughes D.
europepmc +1 more source
Hitting the Sweet Spot: The Impact of Elexacaftor/Tezacaftor/Ivacaftor on Glucose Tolerance in Cystic Fibrosis. [PDF]
Douglas TA, McMahon SK, Wainwright CE.
europepmc +1 more source
Cutaneous and Ocular Rosacea Associated with Elexacaftor, Tezacaftor and Ivacaftor, A Treatment for Cystic Fibrosis: A Case Report. [PDF]
Piednoir A +4 more
europepmc +1 more source
Response to: ‘Lumacaftor/ivacaftor for patients homozygous for Phe508del-CFTR: should we curb our enthusiasm?’ by Jones and Barry [PDF]
J.S. Elborn +3 more
openalex +1 more source
Arterialized oxygen tension and unfavorable clinical outcomes in pediatric cystic fibrosis. [PDF]
Gaupmann R +8 more
europepmc +1 more source
Real-World Outcomes of Elexacaftor/Tezacaftor/Ivacaftor in Children with Cystic Fibrosis. [PDF]
Perrem L, McNally P.
europepmc +1 more source
Elexacaftor/Tezacaftor/Ivacaftor Effect on Bone Density and Body Composition: A Retrospective Analysis. [PDF]
Trost SU +6 more
europepmc +1 more source

